Hachem, Yasmina
Moride, Yola http://orcid.org/0000-0002-8753-2274
Castilloux, Anne-Marie
Castillon, Genaro
Kalaba, Maja
Néron, Andrée
Gamaoun, Rihab
Martel, Marc O.
Beaulieu, Pierre
Ware, Mark
Vigano, Antonio
Funding for this research was provided by:
Canadian Consortium for the Investigation of Cannabinoids
Collège des Médecins du Québec
Canopy Growth Corporation
Alan Edwards Pain Management Unit of the McGill University Health Centre
Article History
Accepted: 30 October 2023
First Online: 23 November 2023
Declarations
:
: This research was supported by grants from the Canadian Consortium for the Investigation of Cannabinoids, the Collège des Médecins du Québec (CMQ) and unrestricted grants from several licensed cannabis producers (Bedrocan, Mettrum and Tweed; these three companies merged during the study conduct into one company called Canopy Growth Corporation) and nowadays Spectrum Therapeutics is the medical division of Canopy Growth Corporation). Funding for data analysis was received from the Alan Edwards Pain Management Unit of the McGill University Health Centre. Cedars Cancer Foundation and Rossy Cancer Network supported the Medical Cannabis Program in Oncology of the McGill University Health Center, which provided most data on oncology patients to the Quebec Cannabis Registry (QCR). No funding agency had input into the design and conduct of the QCR, although the CMQ was present at development meetings.
: YM, AMC, and GC are employees of YolaRX Consultants, which provides consulting services to the pharmaceutical industry and cannabis manufacturers on topics unrelated to this research. MW and MK were employees of Canopy Growth Corporation (MW: 2018–2022 and MK: 2019–2023). AN is a consultant on request in medical cannabis-related pharmacological assessments and needs for injured workers (Bureau d'évaluation médicale). AV was a member of the Clinical Advisory Board for Tilray, Canopy Growth Corporation, Syqe and EmpowerPharm. Until March 2020, AV was the Research Director of Santé Cannabis, Montreal, Canada. MM, PB, RG, and YH have no competing interest.
: No additional data available.
: There is no code available.
: AV, PB, and MW, contributed to the registry design. YM designed the safety analysis and AMC did the data analysis. All authors contributed to the manuscript preparation. All authors read and approved the final manuscript.
: The project was initially approved by the central research ethics committee of the Ministry of Health and Social Services (CCER) of Quebec, which monitored the project for the private clinics and the participating institutions of the health and social services network. On 03 May 2019, the McGill University Health Centre Research Ethics Board took over the role of the CCER for the QCR.
: All participants provided informed consent to participate in the registry. Information is anonymous and only aggregate data are reported.
: Not applicable.